Cellulitis - I-Cellulitis
☆ Emiphumeleni ka-2022 ye-Stiftung Warentest evela eJalimane, ukwaneliseka kwabathengi nge-ModelDerm bekungaphansi kancane kunokuxhumana okukhokhelwayo kwe-telemedicine.
Umlenze uyindawo evamile ku-I-Cellulitis (Cellulitis).
Icala elijwayelekile
Ukuphulukisa isigaba.
References
Cellulitis ukutheleleka kwesikhumba okujwayelekile kwebhaktheriya. Kuthinta abantu abangaphezu kwezigidi ezingu-14 ngonyaka e-United States. Kuholela cishe ku-$3. 7 billion ezindlekweni zokunakekelwa kwe-ambulensi kanye nokulaliswa esibhedlela kwe-650,000 unyaka ngamunye. Ngokuvamile, i- cellulitis ibonakala njengendawo efudumele, ebomvu esikhumbeni enokuvuvukala nobumnene. Kubangelwa ukutheleleka kwebhaktheriya okungazelelwe okubangela ukuvuvukala kwezingqimba zesikhumba ezijulile kanye nezicubu eziseduze. Alikho ithumba noma ubomvu nalokhu kutheleleka. I-Beta-hemolytic streptococci, ikakhulukazi i-streptococcus yeqembu A (Streptococcus pyogenes) , izigebengu ezivamile, zilandelwa ngu- methicillin-sensitive Staphylococcus aureus.
Cellulitis is a common bacterial skin infection, with over 14 million cases occurring in the United States annually. It accounts for approximately 3.7 billion dollars in ambulatory care costs and 650000 hospitalizations annually. Cellulitis typically presents as a poorly demarcated, warm, erythematous area with associated edema and tenderness to palpation. It is an acute bacterial infection causing inflammation of the deep dermis and surrounding subcutaneous tissue. The infection is without an abscess or purulent discharge. Beta-hemolytic streptococci typically cause cellulitis, generally group A streptococcus (i.e., Streptococcus pyogenes), followed by methicillin-sensitive Staphylococcus aureus. Patients who are immunocompromised, colonized with methicillin-resistant Staphylococcus aureus, bitten by animals, or have comorbidities such as diabetes mellitus may become infected with other bacteria.
Cellulitis is a common bacterial skin infection, with over 14 million cases occurring in the United States annually. It accounts for approximately 3.7 billion dollars in ambulatory care costs and 650000 hospitalizations annually. Cellulitis typically presents as a poorly demarcated, warm, erythematous area with associated edema and tenderness to palpation. It is an acute bacterial infection causing inflammation of the deep dermis and surrounding subcutaneous tissue. The infection is without an abscess or purulent discharge. Beta-hemolytic streptococci typically cause cellulitis, generally group A streptococcus (i.e., Streptococcus pyogenes), followed by methicillin-sensitive Staphylococcus aureus. Patients who are immunocompromised, colonized with methicillin-resistant Staphylococcus aureus, bitten by animals, or have comorbidities such as diabetes mellitus may become infected with other bacteria.
Cellulitis ukutheleleka kwebhaktheriya esikhumbeni nasezicutshini ezithambile. Kwenzeka uma kunezinkinga ngomgoqo wokuvikela wesikhumba, amasosha omzimba, noma ukujikeleza kwegazi. Isifo sikashukela, ukukhuluphala, kanye nokuguga kwandisa amathuba okuthi cellulitis ngokuthinta lezi zindawo. Siphinde sibheke okutholwe kamuva ekuxilongeni i- cellulitis , okugqamisa ukubaluleka kokuxilongwa okunembile njengoba izimo ezifana nokushoda kwe-venous, i-eczema, i-deep vein thrombosis, kanye ne-gout ngokuvamile kudidaniswa ne-cellulitis. Ama-antibiotic asetshenziselwa ukwelapha cellulitis akhethwa ngokucophelela ukuze aqondise amagciwane avamile ngaphandle kokukhuthaza ukumelana nama-antibiotic. Siphinde sikhulume ngama-antibiotic amasha agunyazwe i- cellulitis. Cellulitis ivame ukubuya ngenxa yezinto eziyingozi eziqhubekayo kanye nokulimala ohlelweni lwe-lymphatic.
Cellulitis is a bacterial infection of the skin and soft tissues. It happens when there are issues with the skin's protective barrier, the immune system, or blood circulation. Diabetes, obesity, and old age increase the chances of cellulitis by affecting these areas. We also look at recent findings on diagnosing cellulitis, highlighting the importance of accurate diagnosis since conditions like venous insufficiency, eczema, deep vein thrombosis, and gout are often confused with cellulitis. Antibiotics used to treat cellulitis are chosen carefully to target common bacteria without encouraging antibiotic resistance. We also talk about new antibiotics approved for cellulitis. Cellulitis often comes back because of ongoing risk factors and damage to the lymphatic system..
Cellulitis is a bacterial infection of the skin and soft tissues. It happens when there are issues with the skin's protective barrier, the immune system, or blood circulation. Diabetes, obesity, and old age increase the chances of cellulitis by affecting these areas. We also look at recent findings on diagnosing cellulitis, highlighting the importance of accurate diagnosis since conditions like venous insufficiency, eczema, deep vein thrombosis, and gout are often confused with cellulitis. Antibiotics used to treat cellulitis are chosen carefully to target common bacteria without encouraging antibiotic resistance. We also talk about new antibiotics approved for cellulitis. Cellulitis often comes back because of ongoing risk factors and damage to the lymphatic system..
Abantu abaningi baya ezibhedlela noma ezindlini zezimo eziphuthumayo ukuze bathole izifo zesikhumba ezibangelwa amagciwane. Staphylococcus aureus igciwane eliyinhloko elidala lezi zifo, futhi sekuya kuba nzima ukuyelapha ngoba ezinye izinhlobo azikwazi ukumelana nemithi elwa namagciwane.
Acute bacterial skin and skin-structure infections are a common reason for seeking care at acute healthcare facilities, including emergency departments. Staphylococcus aureus is the most common organism associated with these infections, and the emergence of community-associated methicillin-resistant Staphylococcus aureus (MRSA) has represented a considerable challenge in their treatment.
Acute bacterial skin and skin-structure infections are a common reason for seeking care at acute healthcare facilities, including emergency departments. Staphylococcus aureus is the most common organism associated with these infections, and the emergence of community-associated methicillin-resistant Staphylococcus aureus (MRSA) has represented a considerable challenge in their treatment.
Staphylococcus aureus ingahlukaniswa ngezinhlobo ezimbili ngokuya ngempendulo yazo kuma-antibiotics: methicillin-sensitive Staphylococcus aureus (MSSA) , methicillin-resistant Staphylococcus aureus (MRSA) . Emashumini ambalwa eminyaka adlule, ngenxa yokuvela kwamagciwane kanye nokusetshenziswa ngokweqile kwama-antibiotics, ukumelana kwe- S. Aureus kwezidakamizwa bekulokhu kukhuphuka, okuholela ekwenyukeni komhlaba wonke kumazinga okutheleleka angu- MRSA.
According to the sensitivity to antibiotic drugs, S. aureus can be divided into methicillin-sensitive Staphylococcus aureus (MSSA) and methicillin-resistant Staphylococcus aureus (MRSA). In recent decades, due to the evolution of bacteria and the abuse of antibiotics, the drug resistance of S. aureus has gradually increased, the infection rate of MRSA has increased worldwide.
According to the sensitivity to antibiotic drugs, S. aureus can be divided into methicillin-sensitive Staphylococcus aureus (MSSA) and methicillin-resistant Staphylococcus aureus (MRSA). In recent decades, due to the evolution of bacteria and the abuse of antibiotics, the drug resistance of S. aureus has gradually increased, the infection rate of MRSA has increased worldwide.
To review the salient features of the management of severe skin and soft tissue infections (SSTIs), including toxic shock syndrome, myonecrosis/gas gangrene, and necrotizing fasciitis.
Imilenze nobuso yizindawo ezivame kakhulu ezithintekayo. Izinto eziyingozi zihlanganisa ukukhuluphala, ukuvuvuka kwemilenze nokuguga. Amagciwane avame ukubandakanyeka kakhulu yi-streptococci ne-Staphylococcus aureus.
Ukwelashwa ngokuvamile kwenziwa ngama-antibiotics athathwe ngomlomo, njenge-cephalexin, i-amoxicillin noma i-cloxacillin. Cishe u-95% wabantu ungcono ngemva kwezinsuku eziyi-7 kuya kweziyi-10 zokwelashwa. Nokho, labo abanesifo sikashukela ngokuvamile baba nemiphumela emibi kakhulu.
I-Cellulitis isifo esivamile, futhi e-United Kingdom, i-cellulitis yayiyimbangela yokulaliswa esibhedlela ngo-1.6%. I-Cellulitis ngo-2015 yaholela ekufeni kwabantu ababalelwa ku-16,900 emhlabeni jikelele.
○ Ukwelashwa - Izidakamizwa ze-OTC
I-cellulitis ethuthukisiwe idinga ukwelashwa ngama-antibiotic anqunywe udokotela kuphela. Uma isilonda sikhula ngokushesha futhi sihambisana nomkhuhlane nokugodola, kuhle ukubonana nodokotela ngokushesha ngangokunokwenzeka.
Ukufaka i-over-the-counter antibiotic oint ezilonda zakuqala kungasiza. Uma amafutha agcotshwa azacile kakhulu, angase angasebenzi nhlobo.
#Polysporin
#Bacitracin
#Betadine
Sebenzisa izidambisi zinhlungu ze-OTC njenge-acetaminophen ukuze udambise izinhlungu.
#Ibuprofen
#Naproxen
#Acetaminophen
Gcina izinyawo zihlanzekile futhi uphathe unyawo lomsubathi ngoba unyawo lomsubathi lwandisa ingozi ye-cellulitis.
○ Ukwelashwa
#First-generation cephalosporins (e.g. Cefradine)
#Bacterial culture
#Third-generation cephalosporins (e.g. Cefditoren Pivoxil)